intergroup rhabdomyosarcoma study post-surgical clinical group iiib: localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking)
tumor stage finding
intergroup rhabdomyosarcoma study post-surgical clinical group iv: any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor